Abstract:Due to the complexity and variability of the cellular metabolic process and the physiological environment inside and outside the cell, higher requirements are needed on the application of DNA molecular logic gate in cell analysis. In addition, heterogeneity of tumor cells tends to lead to false positives in the clinical diagnosis of a single target, even those with the same cancer type. To address these issues above, we have developed a novel DNA molecular logic gate responsive nanomachine for bispecific recognition and computation of cell membranes. Only when two membrane proteins, MUC1 and EpCAM as model proteins, exist simultaneously, the DNA molecular logic gate can be activated to perform "AND" logic operation and generate amplified "ON" fluorescence signal from the cell membrane. Therefore, our proposed dual-specific "recognition-biocomputing" DNA molecular logic gate has achieved highly accurate imaging analysis of dual-target membrane proteins in situ. Furthermore, the logic gate responsive DNA nanomachine can also be used to analyze target cells in complex cell samples with excellent specificity, which will meet the needs of biomedicine and their application in clinical diagnosis and provide new tools for the biomedical application of DNA molecular logic gates in complex cell systems.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acssensors.0c01166?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acssensors.0c01166</a>.Sequences of DNA oligonucleotides used in this work (Table S1). Schematic diagram of the digestion of PA1 by phi29 DNA polymerase and digestion of 1 μM PA1 by phi29 DNA polymerase for 0–60 min (Figure S1). Schematic diagram of the digestion of PA1-CT by phi29 DNA polymerase and digestion of 1 μM PA1 by phi29 DNA polymerase in the presence of 0–2.5 μM CT (Figure S2). Immunofluorescence of mucin (MUC1) from three cell lines and immunofluorescence of epithelial adhesion molecules (EpCAM) from three cell lines. Scale bar = 20 μm (Figure S3). Western blotting results of MUC1 and EpCAM expression from three cell lines (Figure S4). Fluorescence microscopy images of MCF-7 cells incubated in DNA nanomachine for different times (0–90 min). Scale bar = 20 μm (Figure S5). Fluorescence microscopy images and fluorescence intensity statistics of different rolling circle amplification times after the interaction of DNA nanomachine with the cell membrane surface. Scale bar = 20 μm (Figure S6). Schematic diagram of fluorophore-labeled DNA ternary complex, fluorescence intensity analysis of assembly of fluorophore-labeled DNA ternary complex, and confocal laser scanning microscopy images of three cell lines incubated with fluorophore-labeled DNA nanomachine. Scale bar = 20 μm (Figure S7). Study on the amplification efficiency of logic gate responsive DNA nanomachine. Confocal laser scanning microscopy images of MCF-7 cells incubated with different DNA assemblies: (A) green fluorescence (FAM) and (B) red fluorescence (Cy5). (C, D) Fluorescence intensity statistics of cell imaging from (A) and (B) by ImageJ software. Scale bar = 20 μm (Figure S8) (<a class="ext-link" href="/doi/suppl/10.1021/acssensors.0c01166/suppl_file/se0c01166_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

Endogenous AND Logic DNA Nanomachine for Highly Specific Cancer Cell Imaging

On-Site-Activated Transmembrane Logic DNA Nanodevice Enables Highly Specific Imaging of Cancer Cells by Targeting Tumor-Related Nucleolin and Intracellular MicroRNA

An enzymatically activated self-powered and self-recycled strategy for in situ tumor cell-specific molecular imaging

A "dual-key-and-lock" DNA nanodevice enables spatially controlled multimodal imaging and combined cancer therapy

Construction of an Exogenously and Endogenously Co-Activated DNA Logic Amplifier for Highly Reliable Intracellular MicroRNA Imaging

A reverberating triple AND logic gate nanomachine for intracellular multi-enzyme tracking and MicroRNA detection

Construction of an endogenously activated catalytic DNA circuit for highly robust in vivo microRNA imaging

Self‐Assembled DNA Nanospheres Driven by Carbon Dots for MicroRNAs Imaging in Tumor via Logic Circuit

Cell Membrane-Anchored AND Logic Gate Aptasensor for Tumor Cell-Specific Imaging with Improved Accuracy

Activating a DNA Nanomachine Via Computation Across Cancer Cell Membranes for Precise Therapy of Solid Tumors.

DNA logic gate for cancer cells identification, detection, and modulation of cell–cell interactions

Logic Signal Amplification System for Sensitive Electrochemiluminescence Detection and Subtype Identification of Cancer Cells

Construction of a Ternary Complex Based DNA Logic Nanomachine for a Highly Accurate Imaging Analysis of Cancer Cells

Extracellular Ion-Responsive Logic Sensors Utilizing DNA Dimeric Nanoassemblies on Cell Surface and Application to Boosting AS1411 Internalization

Enzymatically Cyclic Activated Biosensor Based on a Tetrahedral DNA Framework for Precise Tumor in Situ Molecular Imaging

Enzymatically Activated Autonomous-Motion DNAzyme Signal Amplification Strategy for Tumor Cell-Specific Molecular Imaging with Improved Spatial Specificity

Endogenous Protease-Activatable Nanosensor Based on PNA-Peptide-DNA Engineering for AND-Gated and Dual-Model Detection of MicroRNA in Single Living Tumor Cells

Prolonged near-infrared fluorescence imaging of microRNAs and proteases in vivo by aggregation-enhanced emission from DNA-AuNCs Nanomachines

Near-Infrared-Light-Mediated DNA-Logic Nanomachine for Bioorthogonal Cascade Imaging of Endogenous Interconnected MicroRNAs and Metal Ions

Intelligent Reconfiguration‐Promoted Cellular Internalization of Core–Shell DNA Nanoprobe Equipped with Successive Dual Stimuli‐Responsive Protective Satellites for Amplification Fluorescence Imaging of Tumor Cells

Prolonged Near-Infrared Fluorescence Imaging of Micrornas and Proteases in Vivo by Aggregation-Enhanced Emission from DNA-AuNC Nanomachines.